NCT02958696View on ClinicalTrials.gov

Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Bioavailability and Pharmacokinetics
Interventions
DRUG

HTL0018318

Two single doses of active drug (low, mid or high dose either as aqueous solution or capsule) separated by a washout of at least 12 days.

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

All Listed Sponsors
lead

Nxera Pharma UK Limited

INDUSTRY

NCT02958696 - Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules | Biotech Hunter | Biotech Hunter